ABC News has reported on this new study that was published in the medical journal Clinical Infectious Diseases that has discovered that blood received from donors in the U.S. had coronavirus antibodies in the blood which suggests that the coronavirus was in the U.S. as early as mid-December 2019 however widespread community transmission wasn't likely until late February 2020 according to the study:
Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020 | Clinical Infectious Diseases | Oxford Academic (oup.com)
Coronavirus likely in US as early as December 2019: Study - ABC News (go.com)
Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020 | Clinical Infectious Diseases | Oxford Academic (oup.com)
Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020
Background
SARS-CoV-2, the virus that causes COVID-19 disease, was first identified in Wuhan, China in December 2019, with subsequent worldwide spread. The first U.S. cases were identified in January 2020.
Methods
To determine if SARS-CoV-2 reactive antibodies were present in sera prior to the first identified case in the U.S. on January 19, 2020, residual archived samples from 7,389 routine blood donations collected by the American Red Cross from December 13, 2019 to January 17, 2020, from donors resident in nine states (California, Connecticut, Iowa, Massachusetts, Michigan, Oregon, Rhode Island, Washington, and Wisconsin) were tested at CDC for anti-SARS-CoV-2 antibodies. Specimens reactive by pan-immunoglobulin (pan Ig) enzyme linked immunosorbent assay (ELISA) against the full spike protein were tested by IgG and IgM ELISAs, microneutralization test, Ortho total Ig S1 ELISA, and receptor binding domain / Ace2 blocking activity assay.
Results
Of the 7,389 samples, 106 were reactive by pan Ig. Of these 106 specimens, 90 were available for further testing. Eighty four of 90 had neutralizing activity, 1 had S1 binding activity, and 1 had receptor binding domain / Ace2 blocking activity >50%, suggesting the presence of anti-SARS-CoV-2-reactive antibodies. Donations with reactivity occurred in all nine states.
Conclusions
These findings suggest that SARS-CoV-2 may have been introduced into the United States prior to January 19, 2020.
Coronavirus likely in US as early as December 2019: Study - ABC News (go.com)
December 1, 2020
The coronavirus may have been present in the United States weeks earlier than scientists realized, according to new government research.
While COVID-19 cases were first identified in China in December, the United States did not report its first case until late January.
A study published in the journal Clinical Infectious Diseases Monday suggests that the virus was present in the United States as early as last December.
To come to that conclusion, Centers for Disease Control and Prevention scientists analyzed American Red Cross blood donations collected between Dec. 13, 2019, and Jan. 17, 2020, and found evidence of coronavirus antibodies in 106 out of 7,389 blood donations.
"SARS-CoV-2 infections may have been present in the U.S. in December 2019, earlier than previously recognized," the study authors write. "These findings also highlight the value of blood donations as a source for conducting SARS-CoV-2 surveillance."
Of those donations. 39 samples collected from California, Washington and Oregon between Dec. 13 to Dec. 16 contained antibodies. Sixty-seven samples collected in Connecticut, Iowa, Massachusetts, Michigan, Rhode Island and Wisconsin in early January contained COVID-19 antibodies.
The virus' presence in the United States in December does not mean that COVID-19, the disease the virus causes, was spreading widely in the U.S. at that time.
"Widespread community transmission was not likely until late February," the authors note.